查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1429013

流式細胞儀市場：按產品與服務、按技術、按應用、按最終用戶、按地區、機會、預測，2017-2031 年

Flow Cytometry Market Assessment, By Products and Service, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 223 Pages | 商品交期: 3-5個工作天內

價格

全球流式細胞儀市場規模預計將從 2023 年的 50.1 億美元成長到 2031 年的 92 億美元，在 2024-2031 年預測期內複合年增長率為 7.89%。老年人口的增加、慢性病和傳染患者病率的上升正在推動全球流式細胞儀市場的成長。流式細胞儀是一種強大的工具，可應用於免疫學、病毒學、分子生物學、癌症生物學和傳染病監測等多個領域。此外，用於開發最新技術和產品的醫療保健研發支出的增加預計將進一步推動市場。

流式細胞儀的技術進步和新產品的推出正在對該行業產生重大影響。一項值得注意的發展是多家公司將光譜流式細胞儀技術商業化。這些進展對於解決癌症、免疫缺陷疾病和傳染病等疾病日益普及的問題至關重要。預計它將在個人化醫療、藥物發現和開發中發揮重要作用。然而，先進流式細胞儀設備的高成本仍然是一個挑戰，並可能限制其對小型研究機構和新興國家的可用性。此外，政府正在努力改善發展中國家和不發達國家對這些技術的獲取，多家大公司的存在，以及利用公共和私營公司來設計先進的流式細胞術設備和設備。上市公司之間的持續聯盟正在推動市場發展生長。

由於世界各地慢性病和傳染病的增加，對流式細胞儀的需求正在迅速增加。流式細胞儀在癌症、HIV、愛滋病、結核病和許多其他疾病的檢測和分析中發揮重要作用。醫療專業人員對流式細胞儀準確性和靈敏度的認識不斷提高，有助於該行業的發展。

根據世界衛生組織2023年的統計數據，全球每年有4,100萬人因慢性病死亡。它影響所有年齡層的人，無論地區或國家。久坐的生活方式、不健康的飲食以及過度吸煙和飲酒是慢性病盛行率增加的主要危險因子。對疾病及其病原體的早期診斷、準確檢測和早期幹預是對抗日益流行的慢性病的唯一解決方案。這使得醫療保健專業人員能夠使用流式細胞儀和高效測試選項等先進技術，這是主要的成長動力。

本報告調查了全球流式細胞儀市場，並提供了市場概述，以及按產品/服務、技術、應用、最終用戶、地區和進入市場的公司概況劃分的趨勢。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第 4 章 2017-2031 年全球流式細胞儀市場前景

  • 市場規模及預測
  • 按產品/服務
  • 按技術
  • 按用途
  • 按最終用戶
  • 按地區
  • 按公司劃分的市佔率 (%)，2023 年

第 5 章 2017-2031 年全球流式細胞儀市場展望（按地區）

  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第 6 章 市場測繪，2023 年

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

第九章 監理架構與創新

第十章 主要與企業狀況

第11章價格分析

第十二章案例研究

第十三章 主要公司展望

  • Becton, Dickinson and Company
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Sysmex Asia Pacific Pte Ltd.
  • Agilent Technologies, Inc.
  • Sony Biotechnology Inc. LLC
  • Enzo Life Sciences, Inc.
  • Cytek Biosciences, Inc.
  • Sartorius AG
  • Apogee Flow Systems Ltd.
  • Luminex Corporation

第十四章 戰略建議

第十五章 查詢及免責聲明

Product Code: MX11009

Global flow cytometry market is projected to witness a CAGR of 7.89% during the forecast period 2024-2031, growing from USD 5.01 billion in 2023 to USD 9.2 billion in 2031. The increasing geriatric population and the rising prevalence of chronic and infectious diseases drive growth in the global flow cytometry market. Flow cytometry is a powerful tool with applications in multiple disciplines such as immunology, virology, molecular biology, cancer biology, and infectious disease monitoring. Moreover, increasing healthcare expenditure on research and development for the development of the latest technologies and products is further expected to drive the market.

Technological advancements and new product launches in flow cytometry have significantly impacted the industry. One notable development is various companies' commercial launch of spectral flow cytometry technology. These advancements are crucial in addressing the increasing prevalence of diseases, such as cancer, immunodeficiency disorders, and infectious diseases. They are expected to play a vital role in personalized medicine, drug discovery, and development. However, the high cost of advanced flow cytometry equipment remains challenging, potentially limiting accessibility for smaller research facilities or emerging countries. Moreover, government initiatives for improving access to these technologies in developing and under-developed countries, the presence of several leading players, and ongoing partnerships between public and private companies for engineering advanced flow cytometry devices and instruments are facilitating market growth.

Increasing Prevalence of Chronic and Infectious Diseases

There has been a surge in the demand for flow cytometry due to the rising number of chronic and infectious diseases worldwide. Flow cytometry plays a crucial role in detecting and analyzing diseases such as cancer, HIV, AIDS, TB, and many more. Rising awareness among healthcare professionals regarding the accuracy and sensitivity of flow cytometry is contributing to industry growth.

According to WHO 2023 statistics, chronic diseases are responsible for 41 million deaths every year at a global level. This affects people of all age groups, irrespective of their region or country. A sedentary lifestyle, unhealthy diet, and excessive tobacco and alcohol consumption are the leading risk factors for the rising prevalence of chronic diseases. Early diagnosis, accurate detection, and early intervention of the disease and its disease-causing agents are the only solutions to combat the growing prevalence of chronic diseases. This, in turn, enables healthcare professionals to use advanced technologies and highly efficient testing options, such as flow cytometry, acting as a major growth-inducing factor.

Technological Advancements

With a high prevalence of cancer, AIDS, and many other infectious diseases, there is an increasing demand to bring innovation in the flow cytometry industry that can enhance the accuracy of diagnosis and gather insights related to cell structure and functions. Key players are constantly investing in research and development to launch innovative products and instruments to facilitate flow cytometry technological advancements. In June 2023, Becton, Dickinson and Company, a global leader in medical technology, announced that it has launched an innovative automated instrument "BD FACSDuet", that can prepare samples for clinical diagnostics using flow cytometry to improve standardization and reproducibility in cellular diagnostics. The entire sample preparation process, including cocktailing, washing, and centrifuging, is automated by this product. These samples are then transferred to the physically integrated BD FACSLyric clinical flow cytometry system without any human intervention.

Government Initiatives

Government initiatives are playing a significant role in supporting the field of flow cytometry. One notable example is the establishment of the NIST Flow Cytometry Standards Consortium, which brings together industry, academia, and government to identify and address measurement and standard needs across the flow cytometry field. Additionally, government support through funds, grants, and public-private partnerships is contributing to the growth of the flow cytometry market, particularly in the context of research activities such as cancer, stem cell, and HIV studies. These initiatives are crucial in advancing the field of flow cytometry and addressing standardization issues, ultimately contributing to the development of new and innovative technologies in the market.

In August 2022, NanoCellect Biomedical Inc., a leader in developing and manufacturing microfluidic cells, announced that it received a grant of USD 1.8 million from Small Business Innovation Research (SBIR). This fund was granted to assist NanoCellect Biomedical Inc. in developing AI-based imaging flow cytometry technology. It would further help in research programs to develop novel imaging flow cytometry technology.

Growth in Demand for Cell Based Flow Cytometry

Among the technology segment, cell-based flow cytometry segment is expected to grow faster. Cell-based flow cytometry offers the advantage of high throughput and the potential to analyze millions of cells. Flow cytometry provides highly detailed information on single cells for immunotherapy clinical trials, enabling the monitoring of immune responses and the detection of abnormal cells. This technology monitors changes in immune cell phenotype, tracks therapeutic cells, and detects abnormal cells, thus offering a comprehensive view of a disease's micro-environment. In May 2023, Becton, Dickinson and Company, announced global commercial launch of an innovative cell sorting instrument, "BD FACSDiscover", a cell-based technology that will enable researchers to get more insights about cells in various areas, such as drug discovery, immuno-oncology and genomics, which is not possible in traditional flow cytometry experiments. BD FACSDiscover allows the investigation of different aspects of single-cell biology and sorts complex phenotypes for immunologic or genetic discovery.

North America Accounts for the Largest Share in Flow Cytometry Market

North America accounted for the largest share of the global flow cytometry market in 2022, with the United States being a major contributor to this dominance. The region's favorable business environment, substantial government support through funds and grants, and a robust healthcare infrastructure have driven its leadership in the flow cytometry market. Additionally, the high prevalence of HIV/AIDS and cancer has led to a growing focus on the development of treatment options for these target diseases, further propelling the demand for flow cytometry technologies.

The strong presence of key regional players, such as BD, Danaher Corporation, and Thermo Fisher Scientific, has also contributed to North America's market leadership. According to the CDC (Center for Disease Control), 6 out of 10 adults in the US are affected by a chronic disease, whereas 4 out of 10 adults in the USA have 2 or more chronic diseases. Thus, the significant prevalence of chronic and infectious diseases in this region will contribute to increased demand for rapid detection and diagnosis by flow cytometry.

Future Outlook of Global Flow Cytometry Market

Global flow cytometry market is expected to grow in the coming years, due to the growing elderly population and the increasing prevalence of infectious and chronic diseases globally. Technological advancements, research and development, government support, increasing healthcare budget, and collaborative ventures involving medical devices manufacturers, research institutions, and other healthcare providers are anticipated to drive the market growth over the forecasted period.

Key Players Landscape and Outlook

In the flow cytometry market, mergers and acquisitions, partnerships, and distribution agreements are pivotal in driving the global market. These alliances empower firms to adapt to each other's strengths, gain access to new markets and technologies, and pool resources for research and development. Distribution agreements enable companies to expand their market presence. These collaborative initiatives promote innovation, expedite product developments, and contribute to the development and growth of the global flow cytometry market. In February 2023, Luminex Corporation signed an agreement to sell all its flow cytometry & imaging (FCI) business unit assets to Cytek Biosciences. With this strategic acquisition, the company would gain insights into all facets of cellular phenotypes and morphology. There are more than 7,000 instruments, which will be under the Cytek umbrella following this acquisition that will further expand the company's global presence.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Flow Cytometry Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Products and Service
    • 4.2.1. Instruments
      • 4.2.1.1. Cell Analysers
      • 4.2.1.2. Cell Sorters
    • 4.2.2. Kits and Reagents
    • 4.2.3. Software and Services
    • 4.2.4. Others
  • 4.3. By Technology
    • 4.3.1. Cell-based Flow Cytometry
    • 4.3.2. Bead-based Flow Cytometry
  • 4.4. By Application
    • 4.4.1. Oncology
    • 4.4.2. Drug Discovery
    • 4.4.3. Stem Cell Therapy
    • 4.4.4. Hematology
    • 4.4.5. Immunology
    • 4.4.6. Other applications
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Clinical Testing Laboratories
    • 4.5.3. Academic & Research Institutes
    • 4.5.4. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. South America
    • 4.6.4. Asia-Pacific
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Flow Cytometry Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Product and Services
      • 5.1.2.1. Instruments
      • 5.1.2.1.1. Cell Analysers
      • 5.1.2.1.2. Cell Sorters
      • 5.1.2.2. Kits and Reagents
      • 5.1.2.3. Software and Services
      • 5.1.2.4. Others
    • 5.1.3. By Technology
      • 5.1.3.1. Cell-based Flow Cytometry
      • 5.1.3.2. Bead-based Flow Cytometry
    • 5.1.4. By Application
      • 5.1.4.1. Oncology
      • 5.1.4.2. Drug Discovery
      • 5.1.4.3. Stem Cell Therapy
      • 5.1.4.4. Hematology
      • 5.1.4.5. Immunology
      • 5.1.4.6. Other applications
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Clinical Testing Laboratories
      • 5.1.5.3. Academic & Research Institutes
      • 5.1.5.4. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. Value
      • 5.1.6.1.2. Volume
      • 5.1.6.2. By Product and Services
      • 5.1.6.2.1. Instruments
      • 5.1.6.2.1.1. Cell Analysers
      • 5.1.6.2.1.2. Cell Sorters
      • 5.1.6.2.2. Kits and Reagents
      • 5.1.6.2.3. Software and Services
      • 5.1.6.2.4. Others
      • 5.1.6.3. By Technology
      • 5.1.6.3.1. Cell-based Flow Cytometry
      • 5.1.6.3.2. Bead-based Flow Cytometry
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Oncology
      • 5.1.6.4.2. Drug Discovery
      • 5.1.6.4.3. Stem Cell Therapy
      • 5.1.6.4.4. Hematology
      • 5.1.6.4.5. Immunology
      • 5.1.6.4.6. Other applications
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospitals
      • 5.1.6.5.2. Clinical Testing Laboratories
      • 5.1.6.5.3. Academic & Research Institutes
      • 5.1.6.5.4. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product and Services
  • 6.2. By Technology
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Becton, Dickinson and Company
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Thermo Fisher Scientific
  • 13.3. Bio-Rad Laboratories, Inc.
  • 13.4. Miltenyi Biotec B.V. & Co. KG
  • 13.5. Sysmex Asia Pacific Pte Ltd.
  • 13.6. Agilent Technologies, Inc.
  • 13.7. Sony Biotechnology Inc. LLC
  • 13.8. Enzo Life Sciences, Inc.
  • 13.9. Cytek Biosciences, Inc.
  • 13.10. Sartorius AG
  • 13.11. Apogee Flow Systems Ltd.
  • 13.12. Luminex Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 4. Global Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Flow Cytometry Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 10. North America Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 11. North America Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 12. North America Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 17. United States Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 18. United States Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 19. United States Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 23. Canada Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 24. Canada Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 25. Canada Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Mexico Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 30. Mexico Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 31. Mexico Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 35. Europe Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 36. Europe Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 37. Europe Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 42. Germany Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 43. Germany Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 44. Germany Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. France Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 49. France Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 50. France Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 51. France Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Italy Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 55. Italy Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 56. Italy Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 60. United Kingdom Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 61. United Kingdom Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 62. United Kingdom Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 66. Russia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 67. Russia Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 68. Russia Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 72. Netherlands Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 73. Netherlands Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 74. Netherlands Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. Spain Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 79. Spain Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 80. Spain Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 84. Turkey Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 85. Turkey Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 86. Turkey Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Poland Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 91. Poland Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 92. Poland Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 96. South America Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 97. South America Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 98. South America Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Brazil Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 104. Brazil Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 105. Brazil Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 109. Argentina Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 110. Argentina Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 111. Argentina Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 115. Asia-Pacific Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 116. Asia-Pacific Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 117. Asia-Pacific Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 120. India Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 122. India Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 123. India Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 124. India Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 125. India Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 128. China Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 129. China Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 130. China Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 131. China Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 134. Japan Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 135. Japan Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 136. Japan Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 140. Australia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 141. Australia Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 142. Australia Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 146. Vietnam Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 147. Vietnam Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 148. Vietnam Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. South Korea Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 153. South Korea Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 154. South Korea Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 158. Indonesia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 159. Indonesia Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 160. Indonesia Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 164. Philippines Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 165. Philippines Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 166. Philippines Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 170. Middle East & Africa Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 171. Middle East & Africa Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 172. Middle East & Africa Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Saudi Arabia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 178. Saudi Arabia Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 179. Saudi Arabia Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. UAE Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 184. UAE Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 185. UAE Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 189. South Africa Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 190. South Africa Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 191. South Africa Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023